The U.S. Food and Drug Administration has approved a video game for treating attention deficit hyperactivity disorder in children. This is the first time the agency has done so. Also, according to the FDA, the game can improve attention function.
EndeavorRx, built by Boston-based Akili Interactive Labs, requires a prescription. Its developers designed it for children ages 8 to 12 years old with certain ADHD symptoms.
Fox Business reported that the FDA says it looked at data from multiple studies in more than 600 children.
“A video of the game shows a character traveling a racecourse-like path in a hover board. Sensory and motor tasks are designed to help the player improve cognitive functioning,” also said the report.
“The EndeavorRx device offers a non-drug option for improving symptoms associated with ADHD in children and is an important example of the growing field of digital therapy and digital therapeutics,” said Jeffrey Shuren from the FDA.
BBC also reported that a study published in a health journal said that after four weeks of EndeavorRx treatment, one-third of children had seen an improvement in their concentration.
“We’re proud to make history today with FDA’s decision,” said Akili CEO Eddie Martucci. “We’re using technology to help treat a condition in an entirely new way as we directly target neurological function through medicine that feels like entertainment,” he then added.